-
UTI Healthcare IDCW-P
Equity healthcare
Overview ( as on 05/09/25 )
NAV
₹226.55
Last change
₹0.47 +0.0%
Fund Size (AUM)
1146.13 Cr
Performance
19.01% (5Y)
Fund Details
UTI Healthcare IDCW-P
as of 05/09/25
AUM
1146.13 Cr
Expense Ratio
2.25 %
Benchmark
BSE Healthcare TR INR
ISIN
INF789F01679
Fund Manager
Kamal Gada
Exit Load
1.0% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| UTI Healthcare IDCW-P | 3.23% | 25.73% | 19.01% |
| BSE Healthcare TR INR | 1.03% | 23.76% | 18.86% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
9.84% |
Cipla Ltd |
5.43% |
Ajanta Pharma Ltd |
4.8% |
Lupin Ltd |
4.29% |
Procter & Gamble Health Ltd |
4.13% |
Dr Reddy's Laboratories Ltd |
3.99% |
Glenmark Pharmaceuticals Ltd |
3.54% |
Fortis Healthcare Ltd |
3.48% |
Apollo Hospitals Enterprise Ltd |
3.47% |
Gland Pharma Ltd |
3.01% |
Sector Allocation
Healthcare |
98.94% |
Basic Materials |
1.06% |
Asset Allocation
-
98%
Equity
-
2%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
21.54% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
20.84% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
20.98% (5Y)
-
-
SBI Healthcare Opportunities IDCW-R
Equity healthcare-
Returns
-
20.98% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
19.06% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
19.06% (5Y)
-
